tiprankstipranks
Exprivia SpA (IT:XPR)
MILAN:XPR
Holding IT:XPR?
Track your performance easily

Exprivia SpA (XPR) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
4Neutral
11Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Exprivia SpA’s (XPR) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Exprivia SpA is a Buy.
Exprivia SpA’s (XPR) 20-Day exponential moving average is 1.84, while Exprivia SpA’s (XPR) share price is €1.725, making it a Sell.
Exprivia SpA’s (XPR) 50-Day exponential moving average is 1.78, while Exprivia SpA’s (XPR) share price is €1.725, making it a Sell.

Exprivia SpA (XPR) Pivot Points

Dec 22, 2024, 06:10 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.63
1.72
1.76
1.85
1.90
1.99
2.03
Fibonacci
1.72
1.77
1.80
1.85
1.90
1.94
1.99
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Exprivia SpA (XPR) Moving Averages

Dec 22, 2024, 06:10 AM
Period
Simple
Exponential
MA5
1.90Sell
1.84Sell
MA10
1.89Sell
1.86Sell
MA20
1.85Sell
1.84Sell
MA50
1.74Sell
1.78Sell
MA100
1.72Buy
1.73Sell
MA200
1.69Buy
1.70Buy
Exprivia SpA’s (XPR) 10-Day exponential moving average is 1.86, while Exprivia SpA’s (XPR) share price is €1.725, making it a Sell.
Exprivia SpA’s (XPR) 100-Day exponential moving average is 1.73, while Exprivia SpA’s (XPR) share price is €1.725, making it a Sell.
Exprivia SpA’s (XPR) stock price is €1.725 and Exprivia SpA’s (XPR) 50-day simple moving average is 1.74, creating a Sell signal.
Exprivia SpA’s (XPR) stock price is €1.725 and Exprivia SpA’s (XPR) 100-day simple moving average is 1.72, creating a Buy signal.
Exprivia SpA’s (XPR) stock price is €1.725 and Exprivia SpA’s (XPR) 200-day simple moving average is 1.69, creating a Buy signal.

Exprivia SpA (XPR) Technical Indicators

Dec 22, 2024, 06:10 AM
Name
Value
Implied Action
RSI (14)
42.72
Neutral
STOCH (9,6)
17.49
Buy
STOCHRSI (14)
19.45
Buy
MACD (12,26)
0.04
Buy
ADX (14)
27.74
Neutral
Williams %R
-100.00
Buy
CCI (14)
-84.67
Neutral
ATR (14)
0.09
-
Ultimate Oscillator
42.81
Neutral
ROC
-5.74
Sell
Exprivia SpA’s (XPR) Relative Strength Index (RSI) is 42.72, creating a Neutral signal.
Exprivia SpA’s (XPR) Trend Strength Indicator (ADX) is 27.74, creating a Neutral signal.
Exprivia SpA’s (XPR) Commodity Channel Index (CCI) is -84.67, creating a Neutral signal.
Exprivia SpA’s (XPR) Price Rate of Change (ROC) is -5.74, creating a Sell signal.

FAQ

Is XPR a Buy, Hold, or Sell?
Based on XPR’s technical indicators, XPR is a Sell.
    What is XPR’s RSI (14)?
    XPR’s RSI (14) is 42.72, which suggests XPR is a Neutral.
      What is XPR’s MACD?
      XPR’s MACD is 0.04, which suggests XPR is a Buy.
        What is XPR’s 5-day moving average?
        XPR’s 5-day moving average is 1.90, which suggests XPR is a Sell.
          What is XPR’s 20-day moving average?
          XPR 20-day moving average is 1.85, which suggests XPR is a Sell.
            What is XPR’s 50-day moving average?
            XPR’s 50-day moving average is 1.74, which suggests XPR is a Sell.
              What is XPR’s 200-day moving average?
              XPR’s 200-day moving average is 1.69, which suggests XPR is a Buy.
                What is XPR’s Williams % R (14)?
                XPR’s Williams % R (14) is -100.00, which suggests XPR is a Buy.
                  What is XPR’s CCI (14)?
                  XPR’s CCI (14) is -84.67, which suggests XPR is a Neutral.
                    What is the share price of Exprivia SpA?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis